J. Goldman & Co’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-67,500
Closed -$716K 451
2024
Q1
$716K Buy
+67,500
New +$590K 0.02% 296
2018
Q1
Sell
-39,000
Closed -$810K 344
2017
Q4
$810K Buy
+39,000
New +$618K 0.04% 240
2016
Q2
Sell
-30,000
Closed -$789K 328
2016
Q1
$789K Buy
+30,000
New +$2.22M 0.05% 238

Other funds holding BHC

J. Goldman & Co's BHC Position: Q2 2024 in Review

J. Goldman & Co sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 21,137 shares — an estimated $224K sold.

J. Goldman & Co first reported a position in BHC in Q1 2016 and held it in 2 quarters. The position peaked at $408K in Q1 2016. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • J. Goldman & Co reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • J. Goldman & Co sold 21,137 Bausch Health shares in Q2 2024, an estimated $224K.
  • J. Goldman & Co first reported a position in Bausch Health in Q1 2016 and held it in 2 quarters.
  • J. Goldman & Co's Bausch Health position peaked at $408K in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.